Total Payments
$3,877
2024 Payments
$501.66
Companies
18
Transactions
117
Medicare Patients
1,636
Medicare Billing
$352,478
Payment Breakdown by Category
Food & Beverage$3,877 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,877 | 117 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merz North America, Inc. | $1,203 | 10 | $0 (2023) |
| Horizon Therapeutics plc | $462.62 | 26 | $0 (2021) |
| ABBVIE INC. | $374.09 | 6 | $0 (2024) |
| Allergan, Inc. | $333.87 | 14 | $0 (2022) |
| Galderma Laboratories, L.P. | $322.37 | 4 | $0 (2019) |
| Horizon Pharma plc | $230.14 | 14 | $0 (2018) |
| PFIZER INC. | $223.31 | 12 | $0 (2020) |
| Scilex Pharmaceuticals Inc. | $174.46 | 10 | $0 (2023) |
| REVANCE THERAPEUTICS, INC. | $172.82 | 2 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $77.48 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $501.66 | 6 | ABBVIE INC. ($328.84) |
| 2023 | $1,007 | 12 | Merz North America, Inc. ($921.02) |
| 2022 | $431.61 | 10 | Merz North America, Inc. ($281.71) |
| 2021 | $209.82 | 11 | Allergan, Inc. ($75.93) |
| 2020 | $471.82 | 25 | Horizon Therapeutics plc ($267.40) |
| 2019 | $694.39 | 22 | Galderma Laboratories, L.P. ($322.37) |
| 2018 | $215.53 | 11 | Horizon Pharma plc ($73.66) |
| 2017 | $344.37 | 20 | Horizon Pharma plc ($156.48) |
All Payment Transactions
117 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/26/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $30.71 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $223.31 | General |
| 08/16/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $42.32 | General |
| 03/18/2024 | ABBVIE INC. | BOTOX (Biological), UBRELVY | Food and Beverage | In-kind items and services | $32.50 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/08/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 03/01/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $150.69 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/06/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/20/2023 | Merz North America, Inc. | — | Food and Beverage | In-kind items and services | $177.08 | General |
| 10/16/2023 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Sports Early Intervention | ||||||
| 08/02/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $45.00 | General |
| Category: Musculoskeletal | ||||||
| 07/28/2023 | Merz North America, Inc. | — | Food and Beverage | In-kind items and services | $9.36 | General |
| 06/27/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $32.83 | General |
| Category: Musculoskeletal | ||||||
| 06/02/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $311.25 | General |
| Category: Musculoskeletal | ||||||
| 05/30/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: NEUROSCIENCE | ||||||
| 04/28/2023 | Merz North America, Inc. | Xeomin (Biological), Xeomin | Food and Beverage | In-kind items and services | $90.00 | General |
| Category: Musculoskeletal | ||||||
| 03/03/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $225.00 | General |
| Category: Musculoskeletal | ||||||
| 02/14/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Analgesic | ||||||
| 01/11/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $30.50 | General |
| Category: Musculoskeletal | ||||||
| 12/12/2022 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Analgesic | ||||||
| 12/05/2022 | Fidia Pharma USA Inc. | HYMOVIS (Device) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: OSTEOARTHRITIS | ||||||
| 11/10/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/25/2022 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Analgesic | ||||||
| 09/08/2022 | Merz North America, Inc. | — | Food and Beverage | In-kind items and services | $198.71 | General |
| 06/14/2022 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Sports Early Intervention | ||||||
| 05/31/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: FACIAL AESTHETICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 545 | 3,251 | $168,884 | $99,343 |
| 2022 | 13 | 445 | 2,831 | $150,380 | $96,149 |
| 2021 | 13 | 375 | 2,398 | $131,484 | $86,129 |
| 2020 | 11 | 271 | 2,111 | $105,586 | $70,856 |
Total Patients
1,636
Total Services
10,591
Medicare Billing
$352,478
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2023 | 65 | 1,196 | $44,655 | $21,917 | 49.1% |
| 97530 | Therapy procedure using functional activities | Office | 2023 | 47 | 425 | $19,771 | $13,592 | 68.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 211 | $20,505 | $13,292 | 64.8% |
| 97112 | Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2023 | 51 | 375 | $16,265 | $8,985 | 55.2% |
| 97140 | Therapy procedure using manual technique, each 15 minutes | Office | 2023 | 60 | 403 | $14,441 | $6,853 | 47.5% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 23 | 26 | $9,245 | $6,730 | 72.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 66 | $8,359 | $6,147 | 73.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 33 | 33 | $8,331 | $5,502 | 66.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 24 | 54 | $6,193 | $4,612 | 74.5% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 18 | 55 | $7,325 | $4,517 | 61.7% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 14 | 46 | $3,930 | $2,070 | 52.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 17 | $2,885 | $1,995 | 69.2% |
| 97161 | Evaluation for physical therapy, typically 20 minutes | Office | 2023 | 25 | 25 | $2,492 | $1,673 | 67.1% |
| 97162 | Evaluation for physical therapy, typically 30 minutes | Office | 2023 | 12 | 13 | $1,296 | $1,016 | 78.4% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 14 | 46 | $1,132 | $272.84 | 24.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 19 | 213 | $1,592 | $165.69 | 10.4% |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | Office | 2023 | 17 | 47 | $470.00 | $0.91 | 0.2% |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2022 | 58 | 1,169 | $43,781 | $24,422 | 55.8% |
| 97530 | Therapy procedure using functional activities | Office | 2022 | 44 | 417 | $19,634 | $13,884 | 70.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 182 | $16,680 | $11,871 | 71.2% |
| 97140 | Therapy procedure using manual technique, each 15 minutes | Office | 2022 | 47 | 482 | $16,921 | $8,783 | 51.9% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 31 | 32 | $11,973 | $8,502 | 71.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 69 | $8,962 | $6,375 | 71.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 34 | 70 | $8,398 | $6,189 | 73.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 40 | 40 | $8,834 | $5,630 | 63.7% |
About Dr. Marina Babiy, M.D
Dr. Marina Babiy, M.D is a Physical Medicine & Rehabilitation healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1699757765.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marina Babiy, M.D has received a total of $3,877 in payments from pharmaceutical and medical device companies, with $501.66 received in 2024. These payments were reported across 117 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,877).
As a Medicare-enrolled provider, Babiy has provided services to 1,636 Medicare beneficiaries, totaling 10,591 services with total Medicare billing of $352,478. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location New York, NY
- Active Since 11/15/2005
- Last Updated 11/16/2007
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1699757765
Products in Payments
- Xeomin (Biological) $734.58
- BOTOX (Biological) $338.49
- VIMOVO (Drug) $227.53
- RAYOS (Drug) $194.37
- PENNSAID (Drug) $176.82
- DAXXIFY (Drug) $172.82
- LYRICA (Drug) $122.54
- ZTLido (Drug) $113.53
- BOTOX (Drug) $103.84
- DUEXIS (Drug) $94.04
- XTAMPZA (Drug) $77.48
- SPRIX (Drug) $59.29
- Movantik (Drug) $58.12
- ORTHOVISC (Device) $52.43
- COLOGUARD (Device) $50.61
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $45.95
- ZORVOLEX (Drug) $38.40
- GENERAL - PAIN MANAGEMENT (Device) $27.24
- GELSYN 3 (Device) $26.90
- HYMOVIS (Device) $20.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in New York
Heidi Fusco, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $160,307
Physical Medicine & Rehabilitation $160,307
Dr. Kimberly Sackheim, Do, DO
Physical Medicine & Rehabilitation — Payments: $158,974
Physical Medicine & Rehabilitation $158,974
Michael O'dell, Md, MD
Physical Medicine & Rehabilitation — Payments: $103,549
Physical Medicine & Rehabilitation $103,549
Dr. Craig Antell, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $78,788
Physical Medicine & Rehabilitation $78,788
Russell Silver, Md, MD
Physical Medicine & Rehabilitation — Payments: $66,937
Physical Medicine & Rehabilitation $66,937
Ehsan Abdeshahian, Md, MD
Physical Medicine & Rehabilitation — Payments: $54,837
Physical Medicine & Rehabilitation $54,837